Published in Blood Weekly, July 10th, 2003
"Allogeneic stem cell transplantation (SCT) using reduced-intensity conditioning (RIC) has potential to be a promising treatment" for patients with aggressive CLL, researchers in Germany explained.
"Since available clinical data obtained with this novel approach are very limited," P. Dreger and colleagues at Allgemeines Krankenhaus St Georg in Hamburg "performed a survey on this issue."
"Data of 77 patients were collected from 29 European Group for Blood and Marrow Transplantation centers,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.